The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Immune-mediated inflammatory diseases (IMIDs) encompass a wide range of seemingly unrelated conditions, such as multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, asthma, chronic obstructive pulmonary disease, and systemic lupus erythematosus. Despite differing etiologies, these diseases share common inflammatory pathways, which lead to damage in primary target organs and frequently to a plethora of systemic effects as well. The purinergic signaling complex comprising extracellular nucleotides and nucleosides and their receptors, the P2 and P1 purinergic receptors, respectively, as well as catabolic enzymes and nucleoside transporters is a major regulatory system in the body. The purinergic signaling complex can regulate the development and course of IMIDs. Here we provide a comprehensive review on the role of purinergic signaling in controlling immunity, inflammation, and organ function in IMIDs. In addition, we discuss the possible therapeutic applications of drugs acting on purinergic pathways, which have been entering clinical development, to manage patients suffering from IMIDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514 · cited 1×
“Rheumatoid arthritis (RA) is a common autoimmune disease, which causes both joint inflammation and systemic complications, progressive disability, early death, and high socioeconomic costs (McInnes and Schett, 2011).”
BackgroundIntestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · cited 1×
“Bacteria crossing the intestinal barrier activate the mucosal immune system and drive inflammation (Turner, 2009; Cahenzli et al., 2013; Martini et al., 2017).”
BackgroundCytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706 · cited 4×
“The beneficial effect of P2X 7 receptor deficiency in these studies was associated with decreased production of inflammatory cytokines, decreased NF-k B, activation and T reg accumulation (Neves et al., 2014; Hofman et al., 2015; Figliuolo et al., 2017).”
BackgroundInfluentialMultiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
ATP drives lamina propria TH17 cell differentiation
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., et al. (2008) · Nature · doi:10.1038/nature07240 · Cited by 1,089 · cited 2×
“ATP released from intestinal commensal bacteria participates in enteric homeostatic regulatory mechanisms by inducing the differentiation of naturally occurring Th 17 cells, which control bacterial and fungal infections at the mucosal surface (Atarashi et al., 2008).”
BackgroundPurinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Self-citationMartini, E., Krug, S. M., Siegmund, B., Neurath, M. F., & Becker, C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.03.007 · Cited by 668
Development of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625 · cited 1×
“A number of pharmacological tools have been developed to target miRNA pathways (van Rooij and Kauppinen, 2014).”
BackgroundYiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509
Friedman, D. J., Künzli, B. M., A-Rahim, Y. I., Sevigny, J., Berberat, P. O., Enjyoji, K., Csizmadia, E., Friess, H., & Robson, S. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902869106 · Cited by 284 · cited 2×
“In an early study, CD39-deficient mice exhibited increased susceptibility to DSS-induced colitis, which was rescued by exogenously introduced apyrase (Friedman et al., 2009).”
BackgroundP2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis
Zabala, A., Vazquez‐Villoldo, N., Rissiek, B., Gejo, J., Martin, A., Palomino, A., Perez‐Samartín, A., Pulagam, K. R., Lukowiak, M., Capetillo‐Zarate, E., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708743 · Cited by 192
Proietti, M., Cornacchione, V., Rezzonico Jost, T., Romagnani, A., Faliti, C. E., Perruzza, L., Rigoni, R., Radaelli, E., Caprioli, F., Preziuso, S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.010 · Cited by 181
Significance of P2X7 Receptor Variants to Human Health and Disease
Sluyter, R., & Stokes, L. (2011) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221511794839219 · Cited by 147
MicroRNA-125b regulates microglia activation and motor neuron death in ALS
Parisi, C., Napoli, G., Amadio, S., Spalloni, A., Apolloni, S., Longone, P., & Volonté, C. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.153 · Cited by 139
Zhou, L., Qi, X., Potashkin, J. A., Abdul-Karim, F. W., & Gorodeski, G. I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802663200 · Cited by 135
Perruzza, L., Gargari, G., Proietti, M., Fosso, B., D’Erchia, A. M., Faliti, C. E., Rezzonico-Jost, T., Scribano, D., Mauri, L., Colombo, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.061 · Cited by 114 · cited 1×
“That is, ATP, through P2X 7 receptor activation on T follicular helper cells, limits the secretory IgA response to commensal bacteria in the small intestine, thereby leading to the selection of a beneficial commensal microbial community for the host (Proietti et al., 2014; Perruzza et al., 2017).”
BackgroundRejuvenating the immune system in rheumatoid arthritis.
Weyand, C. M., Fujii, H., Shao, L., & Goronzy, J. J. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.180 · Cited by 112 · cited 2×
“Macrophages, DCs, T cells, and B cells accumulate in the joints, where they produce autoantibodies, proinflammatory cytokines, and bone destructive mediators (Weyand et al., 2009).”
BackgroundNeves, A. R., Castelo-Branco, M. T. L., Figliuolo, V. R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H. F., Coutinho, C. M. L. M., Carneiro, A. J. V., Coutinho-Silva, R., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000441201.10454.06 · Cited by 107 · cited 4×
“The beneficial effect of P2X 7 receptor deficiency in these studies was associated with decreased production of inflammatory cytokines, decreased NF-k B, activation and T reg accumulation (Neves et al., 2014; Hofman et al., 2015; Figliuolo et al., 2017).”
BackgroundInfluentialJimenez-Mateos, E. M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L. A., Reschke, C. R., Mooney, C. M., Mooney, C., Lugara, E., Morgan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17486 · Cited by 103
The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders
Ford, A. P., & Undem, B. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00267 · Cited by 95 · cited 1×
“The usefulness of this approach is under-lined by studies showing that allosteric antagonists for P2X 3 , P2X 4 , and P2X 7 had beneficial effects in preclinical models of joint inflammation and asthma (Ford and Undem, 2013).”
BackgroundProphylactic systemic P2X7 receptor blockade prevents experimental colitis
Marques, C. C., Castelo-Branco, M. T., Pacheco, R. G., Buongusto, F., do Rosário, A., Schanaider, A., Coutinho-Silva, R., & de Souza, H. S. P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.012 · Cited by 78
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.
Amadio, S., Montilli, C., Magliozzi, R., Bernardi, G., Reynolds, R., & Volonte, C. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp193 · Cited by 73 · cited 2×
“Brain sections fromMS patients were immunopositive for P2X1, P2X2, P2X3, P2X4, and P2X7 receptors (Amadio et al., 2010).”
BackgroundGibson, D. J., Elliott, L., McDermott, E., Tosetto, M., Keegan, D., Byrne, K., Martin, S. T., Rispens, T., Cullen, G., Mulcahy, H. E., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000566 · Cited by 62 · cited 2×
“In humans with IBD, CD39 expression on T regs was lower compared with healthy patients (Gibson et al., 2015).”
BackgroundLe Gall, S. M., Legrand, J., Benbijja, M., Safya, H., Benihoud, K., Kanellopoulos, J. M., & Bobé, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052161 · Cited by 19 · cited 2×
“…against many nuclear antigens, such as DNA and histones) (Mandik-Nayak et al., 1999), became more resistant with age to P2X 7 receptor-induced shedding of CD62L, pore formation, phosphatidylser-ine exposure, and cell death compared with non-B220 + CD4 – CD8 – lymphocytes (Le Gall et al., 2012).”
Background
Metadata
- Authors
- Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 71
- Issue
- 3
- Pages
- 345-382
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2955083803
- Cited by
- 158
- References
- 28
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.